IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Palo Alto Investors LP

Q2 2023 Holdings

Filed 2023-08-14 | 30 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$158.7M1,831,03512.8%
United Therapeutics Corp(UTHR)COM91307C102$138.5M627,51411.2%
Revance Therapeutics Inc(RVNCEUR)COM761330109$132.3M5,228,60910.7%
Amicus Therapeutics Inc(FOLD)COM03152W109$132.2M10,524,02210.7%
Insmed Inc(INSM)COM457669307$124.3M5,889,49110.0%
Prothena Corp PLC(PRTA)COMG72800108$113.2M1,657,4589.1%
Biogen Inc(BIIB)COM09062X103$108.6M381,2828.8%
Staar Surgical Co(STAA)COM852312305$72.3M1,374,8225.8%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$57.6M2,405,7934.7%
Sage Therapeutics Inc(SG7)COM78667J108$40.4M859,5173.3%
Align Technology Inc(ALGN)COM016255101$26.4M74,6052.1%
Novocure LTD(NVCR)COMG6674U108$24.0M578,1181.9%
Ehealth Inc(EHTH)COM28238P109$22.0M2,739,3791.8%
Alkermes PLC(ALKS)COMG01767105$18.9M603,4001.5%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$12.8M612,6001.0%
Sarepta Therapeutics Inc(SRPT)COM803607100$10.8M94,0300.9%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$10.2M5,675,8760.8%
Anaptysbio Inc(ANAB)COM032724106$8.8M431,2240.7%
Nevro Corp(NVROEUR)COM64157F103$4.7M186,2590.4%
Gossamer BIO Inc(GOSS)COM38341P102$4.2M3,465,1520.3%
Cytokinetics Inc(CYTK)COM23282W605$3.6M111,7170.3%
Travere Therapeutics Inc(TVTX)COM89422G107$2.6M166,0690.2%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$2.1M324,0730.2%
Relmada Therapeutics Inc(RLMD)COM75955J402$1.8M732,4000.1%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$1.7M64,7000.1%
Kezar Life Sciences IncCOM49372L100$1.6M656,2000.1%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$1.3M160,8000.1%
Gritstone Oncology Inc(2JQ)COM39868T105$1.3M666,1270.1%
Tactile Systems Technology I(TCMD)COM87357P100$675.6K27,1000.1%
Urogen Pharma LTD(URGN)COMM96088105$253.6K24,5000.0%